orexo.org
Orexometa description
http://www.orexo.org/
meta description
http://www.orexo.org/
TODAY'S RATING
>1,000,000
Date Range
HIGHEST TRAFFIC ON
Monday
LOAD TIME
Orexo AB
Orexo AB
Bo●●03
Up●●la , 751 05
SE
View this contact
Groth & Co KB
Johan Sjobeck
Box●●●107
Sto●●●olm , 102 32
SE
View this contact
Groth and Co
Johan Sjobeck
PO B●●●●6107
Sto●●●olm , 10232
SE
View this contact
BUY YOUR DOMAIN
Melbourne IT, Ltd (R52-LROR)
WHOIS : whois.publicinterestregistry.net
REFERRED :
PAGES IN
THIS WEBSITE
12
SSL
EXTERNAL LINKS
0
SITE IP
194.169.225.56
LOAD TIME
0 sec
SCORE
6.2
Orexo | orexo.org Reviews
https://orexo.org
meta description
orexo.org
Partnering Opportunities - Orexo
http://www.orexo.org/en/Portfolio/Partnering--Opportunities
Zubsolv for treatment of opioid dependence. We are looking for a partner who will commercialize Zubsolv, buprenorphine/naloxone sublingual tablet for treatment of opioid dependence, in markets outside the United States. Zubsolv has been successfully launched in the U.S. in 2013 with annualized gross sales of more than USD 100 million and continued growth potential. Now we are hoping to repeat this success in other geographies with the right partner. OX51 in acute pain. Current pain management options for...
Interim Report January-September 2015 - Orexo
http://www.orexo.org/en/Investor-Relations/Calendar/Interim-Report-January-September-2015
Interim Report January-September 2015. Interim Report January-September 2015. The Interim Report January-September 2015 will be published on October 22, 2015 at 08:00am. Orexo invites media, investors and analysts to a telephone conference at 2:00pm CET on October 22, 2015, where the Interim Report January-September 2015 will be presented by CEO Nikolaj Sørensen and CFO Henrik Juuel. To access the telephone conference, see below. Please call a few minutes before the scheduled start:. SE: 46 8 5664 2693.
Partnering Opportunities - Orexo
http://www.orexo.org/Portfolio/Partnering--Opportunities
Zubsolv for treatment of opioid dependence. We are looking for a partner who will commercialize Zubsolv, buprenorphine/naloxone sublingual tablet for treatment of opioid dependence, in markets outside the United States. Zubsolv has been successfully launched in the U.S. in 2013 with annualized gross sales of more than USD 100 million and continued growth potential. Now we are hoping to repeat this success in other geographies with the right partner. OX51 in acute pain. Current pain management options for...
About Orexo - Orexo
http://www.orexo.org/en/About-Orexo
Orexo develops improved specialty pharmaceuticals and treatments for new areas of use at a lower cost, in a shorter period of time and at a lower risk by combining known substances with patented proprietary technologies. Edluar is a product for the treatment of short-term insomnia. The specialty pharma company Meda has a global license for Edluar. Kibion was divested as of April 30, 2015. At the end of 2015, the process of identifying a new external partner for OX-MPI was ongoing. Orexo signs license agr...
Information about cookies - Orexo
http://www.orexo.org/en/Pages-not-in-menu/Information-about-cookies
As from 25 July, 2003, new legislation concerning electronic communication is in force in Sweden. The new law stipulates that visitors to a website shall be made aware of what so-called cookies are used for and be offered the option to refuse such use. Orexo does not keep any personal information gathered via the cookies, nor can any information about the visitor be traced. If you wish to avoid the usage of cookies, this may be achieved by setting the security system of your webbrowser so that it aut...
TOTAL PAGES IN THIS WEBSITE
12
Login
Log in to EPiServer CMS 6. Enable automatic logon to this website. If you log in, cookies will be used. A cookie containing login information will be sent to your web browser. If you do not want to receive cookies, you will be unable to log into the website.
Orexo
Interim Report Jan-June 2015. ORX Aug 11, 2015 5:29 PM CET. 6050 SEK 14.7%. US FDA Approves ZUBSOLV for Induction of Buprenorphine Maintenance Therapy in Patients Suffering from Opioid Dependence. ZUBSOLV Market Access Update on Agreement with CVS Caremark and Announcement of New Exclusive Agreement in Managed Medicaid. Number of shares and votes in Orexo. Interim report January-June 2015. Teleconference presenting the new induction label for Zubsolv. Interim Report January-September 2015.
Orexo - Start
Orexo is a fully integrated specialty pharmaceutical company. Board of Directors and Management. Our drug delivery technologies improve pharmaceuticals. Partnerships are critical to our success. We will be recognized for the added value our products bring to patients and societies. Orexo’s share is listed on Nasdaq Stockholm Mid Cap and available as American Depository Receipts (ADRs) on OTCQX in the US. Financial calendar and events. Reports, presentations and audiocasts. Follow Orexo in social media.
Orexo
Interim Report Jan-June 2015. ORX Aug 11, 2015 5:29 PM CET. 6050 SEK 14.7%. US FDA Approves ZUBSOLV for Induction of Buprenorphine Maintenance Therapy in Patients Suffering from Opioid Dependence. ZUBSOLV Market Access Update on Agreement with CVS Caremark and Announcement of New Exclusive Agreement in Managed Medicaid. Number of shares and votes in Orexo. Interim report January-June 2015. Teleconference presenting the new induction label for Zubsolv. Interim Report January-September 2015.
Orexo
Interim Report Jan-June 2015. ORX Aug 11, 2015 5:29 PM CET. 6050 SEK 14.7%. US FDA Approves ZUBSOLV for Induction of Buprenorphine Maintenance Therapy in Patients Suffering from Opioid Dependence. ZUBSOLV Market Access Update on Agreement with CVS Caremark and Announcement of New Exclusive Agreement in Managed Medicaid. Number of shares and votes in Orexo. Interim report January-June 2015. Teleconference presenting the new induction label for Zubsolv. Interim Report January-September 2015.
Orexo
Interim Report Jan-June 2015. ORX Aug 11, 2015 5:29 PM CET. 6050 SEK 14.7%. US FDA Approves ZUBSOLV for Induction of Buprenorphine Maintenance Therapy in Patients Suffering from Opioid Dependence. ZUBSOLV Market Access Update on Agreement with CVS Caremark and Announcement of New Exclusive Agreement in Managed Medicaid. Number of shares and votes in Orexo. Interim report January-June 2015. Teleconference presenting the new induction label for Zubsolv. Interim Report January-September 2015.
order
Harder, stronger, fuller erections. Easier to achieve erections. Thank you so very much! I am getting the biggest, hardest erections I have ever had. As soon as lust stirs the brain-wham! I am 40 but am performing better than when I was 18! I ordered with much trepidation, but now go nowhere with out your product-fantastic, thank you! Jeff T. WA. You guys have given me back my confidence to please my wife of 15 years! When we go on vacation now she doesn't allow me to leave home without it. Doug J. CA.
orexonline.net - orexonline Resources and Information.
This webpage was generated by the domain owner using Sedo Domain Parking. Disclaimer: Sedo maintains no relationship with third party advertisers. Reference to any specific service or trade mark is not controlled by Sedo nor does it constitute or imply its association, endorsement or recommendation.
Blog Terproteksi › Masuk log
Https:/ orexorex.wordpress.com/. Is marked private by its owner. If you were invited to view this site, please log in. Below Read more about privacy settings. Surat Elektronik atau Nama Pengguna. Kehilangan kata sandi Anda? Larr; Kembali ke WordPress.com.
Диета для ребенка при гастроэнтерите | диета при хроническом панкреатите рецепты
Would you like to make this site your homepage? It's fast and easy. Yes, Please make this my home page! Don't show this to me again. Стоимость таблеток для похудания. Диета, ускорить обмен веществ. Диета талая вода е. Категория: пояса для похудания на форуме. Диета для ребенка при гастроэнтерите. Попрошайкой дай покаяться об отчаинии о чем к делу молодого карабинера в гр продукта вы гарантированно потеряете до кг днес ми ме считаха за гнутьё пальцев на кухню в течение нед. Двухконечный искусственный пени...
Коттеджный поселок «Орехов куст» - коттеджный поселок в Казани - продажа земельных участков | Земельные участки на берегу реки Кама | Купить дом в лаищево
Новый микрорайон в городе Лаишево. Коттеджный поселок под Казанью Орехов куст. Здесь есть кафе, магазин, детские и спортивные площадки, где можно играть в футбол и волейбол, мастерские, и многое другое, что сделает жизнь в поселке интересной и насыщенной новыми впечатлениями. Для любителей хоккея зимой заливается каток. Зимние каникулы в нашем микрорайоне не пропадут зря — помимо лыж и хоккея можно гонять по окрестностям на снегокате, строить снежные городки или ледяные скульптуры — все, ...Когда Вы реши...
SOCIAL ENGAGEMENT